4.5 Article

Uterine Neoplasms, Version 1.2014

Journal

Publisher

HARBORSIDE PRESS
DOI: 10.6004/jnccn.2014.0025

Keywords

-

Categories

Ask authors/readers for more resources

Adenocarcinoma of the endometrium (also known as endometrial cancer or more broadly as uterine cancer or carcinoma of the uterine corpus) is the most common malignancy of the female genital tract in the United States. An estimated 49,560 new uterine cancer cases will occur in 2013, with 8190 deaths resulting from the disease. Uterine sarcomas (stromal/mesenchymal tumors) are uncommon malignancies, accounting for approximately 3% of all uterine cancers. The NCCN Guidelines for Uterine Neoplasms describe malignant epithelial carcinomas and uterine sarcomas; each of these major categories contains specific histologic groups that require different management. This excerpt of these guidelines focuses on early-stage disease.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Oncology

Nonsteroidal Anti-inflammatory Drugs and Endometrial Carcinoma Mortality and Recurrence

Theodore M. Brasky, Ashley S. Felix, David E. Cohn, D. Scott McMeekin, David G. Mutch, William T. Creasman, Premal H. Thaker, Joan L. Walker, Richard G. Moore, Shashikant B. Lele, Saketh R. Guntupalli, Levi S. Downs, Christa I. Nagel, John F. Boggess, Michael L. Pearl, Olga B. Ioffe, Kay J. Park, Shamshad Ali, Louise A. Brinton

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2017)

Article Oncology

Recruiting Endometrial Cancer Survivors to Studies Examining Lifestyle Behaviors and Quality of Life: Challenges Faced and Lessons Learned

Alexander R. Lucas, Brian C. Focht, David E. Cohn, Maryanna D. Klatt, Janet Buckworth

JOURNAL OF CANCER EDUCATION (2018)

Article Obstetrics & Gynecology

International Society of Gynecological Pathologists (ISGyP) Endometrial Cancer Project: Guidelines From the Special Techniques and Ancillary Studies Group

Kathleen R. Cho, Kumarasen Cooper, Sabrina Croce, Bojana Djordevic, Simon Herrington, Brooke Howitt, Pei Hui, Philip Ip, Martin Koebel, Sigurd Lax, Bradley J. Quade, Patricia Shaw, August Vidal, Anna Yemelyanova, Blaise Clarke, Lora Hedrick Ellenson, Teri A. Longacre, Ie-Ming Shih, W. Glenn McCluggage, Anais Malpica, Esther Oliva, Vinita Parkash, Xavier Matias-Guiu

INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY (2019)

Article Oncology

Uterine Neoplasms, Version 1.2018 Clinical Practice Guidelines in Oncology

Wui-Jin Koh, Nadeem R. Abu-Rustum, Sarah Bean, Kristin Bradley, Susana M. Campos, Kathleen R. Cho, Hye Sook Chon, Christina Chu, David Cohn, Marta Ann Crispens, Shari Damast, Oliver Dorigo, Patricia J. Eifel, Christine M. Fisher, Peter Frederick, David K. Gaffney, Suzanne George, Ernest Han, Susan Higgins, Warner K. Huh, John R. Lurain, Andrea Mariani, David Mutch, Christa Nagel, Larissa Nekhlyudov, Amanda Nickles Fader, Steven W. Remmenga, R. Kevin Reynolds, Todd Tillmanns, Stefanie Ueda, Emily Wyse, Catheryn M. Yashar, Nicole R. McMillian, Jillian L. Scavone

JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2018)

Article Obstetrics & Gynecology

Receipt of adjuvant endometrial cancer treatment updates according to race: an NRG Oncology/Gynecologic Oncology Group 210 Study

Ashley S. Felix, David E. Cohn, Theodore M. Brasky, Richard Zaino, Kay Park, David G. Mutch, William T. Creasman, Premal H. Thaker, Joan L. Walker, Richard G. Moore, Shashikant B. Lele, Saketh R. Guntupalli, Levi S. Downs, Christa Nagel, John F. Boggess, Michael L. Pearl, Olga B. Ioffe, Marcus E. Randall, Louise A. Brinton

AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2018)

Review Oncology

Cervical Cancer, Version 3.2019

Wui-Jin Koh, Nadeem R. Abu-Rustum, Sarah Bean, Kristin Bradley, Susana M. Campos, Kathleen R. Cho, Hye Sook Chon, Christina Chu, Rachel Clark, David Cohn, Marta Ann Crispens, Shari Damast, Oliver Dorigo, Patricia J. Eifel, Christine M. Fisher, Peter Frederick, David K. Gaffney, Ernest Han, Warner K. Huh, John R. Lurain, Andrea Mariani, David Mutch, Christa Nagel, Larissa Nekhlyudov, Amanda Nickles Fader, Steven W. Remmenga, R. Kevin Reynolds, Todd Tillmanns, Stefanie Ueda, Emily Wyse, Catheryn M. Yashar, Nicole R. McMillian, Jillian L. Scavone

JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2019)

Article Oncology

Multiclonality and Marked Branched Evolution of Low-Grade Endometrioid Endometrial Carcinoma

Lorena Lazo de la Vega, Mia C. Samaha, Kevin Hu, Nolan R. Bick, Javed Siddiqui, Daniel H. Hovelson, Chia-Jen Liu, Cody S. Carter, Kathleen R. Cho, Andrew P. Sciallis, Scott A. Tomlins

MOLECULAR CANCER RESEARCH (2019)

Article Oncology

Lineage tracing suggests that ovarian endosalpingiosis does not result from escape of oviductal epithelium

Yisheng Wang, Michael S. Sessine, Yali Zhai, Courtney Tipton, Kevin McCool, Rork Kuick, Denise C. Connolly, Eric R. Fearon, Kathleen R. Cho

JOURNAL OF PATHOLOGY (2019)

Article Medicine, Research & Experimental

Trp53 null and R270H mutant alleles have comparable effects in regulating invasion, metastasis, and gene expression in mouse colon tumorigenesis

Jinyu Tang, Ying Feng, Rork Kuick, Megan Green, Maranne Green, Naoya Sakamoto, Yuki Kurosu, Jeffry Lin, Kathleen R. Cho, Eric R. Fearon

LABORATORY INVESTIGATION (2019)

Article Obstetrics & Gynecology

Preoperative predictors of endometrial cancer at time of hysterectomy for endometrial intraepithelial neoplasia or complex atypical hyperplasia

Monica Hagan Vetter, Blair Smith, Jason Benedict, Erinn M. Hade, Kristin Bixel, Larry J. Copeland, David E. Cohn, Jeffrey M. Fowler, David O'Malley, Ritu Salani, Floor J. Backes

AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2020)

Article Oncology

Carboplatin and Paclitaxel for Advanced Endometrial Cancer: Final Overall Survival and Adverse Event Analysis of a Phase III Trial (NRG Oncology/GOG0209)

David S. Miller, Virginia L. Filiaci, Robert S. Mannel, David E. Cohn, Takashi Matsumoto, Krishnansu S. Tewari, Paul DiSilvestro, Michael L. Pearl, Peter A. Argenta, Matthew A. Powell, Susan L. Zweizig, David P. Warshal, Parviz Hanjani, Michael E. Carney, Helen Huang, David Cella, Richard Zaino, Gini F. Fleming

JOURNAL OF CLINICAL ONCOLOGY (2020)

Article Oncology

Depot-Medroxyprogesterone Acetate Use Is Associated with Decreased Risk of Ovarian Cancer: The Mounting Evidence of a Protective Role of Progestins

Minh Tung Phung, Alice W. Lee, Anna H. Wu, Andrew Berchuck, Kathleen R. Cho, Daniel W. Cramer, Jennifer Anne Doherty, Marc T. Goodman, Gillian E. Hanley, Holly R. Harris, Karen McLean, Francesmary Modugno, Kirsten B. Moysich, Bhramar Mukherjee, Joellen M. Schildkraut, Kathryn L. Terry, Linda J. Titus, Susan J. Jordan, Penelope M. Webb, Malcolm C. Pike, Celeste Leigh Pearce

Summary: The use of combined oral contraceptives and progestin-only contraceptives is associated with a decreased risk of ovarian cancer. Specifically, the injectable progestin-only contraceptive depot-medroxyprogesterone acetate (DMPA) was found to be associated with a 35% decreased risk of ovarian cancer, with a significant trend of decreasing risk with increasing duration of use. Some studies showed an inverse association between DMPA use and ovarian cancer risk, while others showed increased risk, indicating a need for further investigation into the mechanism of this association.

CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2021)

Article Oncology

Altering the Microbiome Inhibits Tumorigenesis in a Mouse Model of Oviductal High-Grade Serous Carcinoma

Lixing Chen, Yali Zhai, Yisheng Wang, Eric R. Fearon, Gabriel Nunez, Naohiro Inohara, Kathleen R. Cho

Summary: Bacteria play a role in the pathogenesis of ovarian cancer, with evidence from an in vivo mouse model. Altering the microbiome with antibiotics may enhance the response of HGSC to immunotherapy, as demonstrated in this study.

CANCER RESEARCH (2021)

Article Oncology

Up-Front Multigene Panel Testing for Cancer Susceptibility in Patients With Newly Diagnosed Endometrial Cancer: A Multicenter Prospective Study

Monica D. Levine, Rachel Pearlman, Heather Hampel, Casey Cosgrove, David Cohn, Alexis Chassen, Adrian Suarez, David A. Barrington, Joseph P. McElroy, Steven Waggoner, John Nakayama, Caroline Billingsley, Kim Resnick, Stephen Andrews, Sareena Singh, Eric Jenison, Aine Clements, Robert Neff, Paul J. Goodfellow

Summary: This prospective multicenter study revealed actionable germline variants in 10% of unselected women with newly diagnosed EC, supporting the use of up-front MGPT for all EC patients. The discovery that BRCA1 or BRCA2 heterozygotes frequently had type II cancers points to therapeutic opportunities for women with aggressive histologic EC subtypes.

JCO PRECISION ONCOLOGY (2021)

Article Oncology

Prehabilitation for medically frail patients undergoing surgery for epithelial ovarian cancer: a cost-effectiveness analysis

Jhalak Dholakia, David E. Cohn, J. Michael Straughn, Sarah E. Dilley

Summary: The study assessed the potential cost-effectiveness of prehabilitation in medically frail patients undergoing surgery for EOC, finding that prehabilitation was not only more effective but also cost-saving, by reducing complication rates and decreasing care facility requirements to save healthcare costs.

JOURNAL OF GYNECOLOGIC ONCOLOGY (2021)

No Data Available